Last Updated on June 22, 2023

Frontiers in Anti-infective Drug Discovery- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers B.V.

Abbreviation: Front. Anti-infect. Drug Discov.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.00

SJR

 0.131

h-Index

 2

Rank

 23295

Important Details

Title Frontiers in Anti-infective Drug Discovery
Standard Abbreviation Front. Anti-infect. Drug Discov.
Type of Publication Book series
Discipline Drug Discovery (Q4); Infectious Diseases (Q4); Molecular Medicine (Q4)
Impact Score 1.00
SCImago Journal Rank (SJR) 0.131
h-index 2
Overall Rank 23295
Publisher Name Bentham Science Publishers B.V.
Publication Country Netherlands
International Standard Serial Number (ISSN) 1879663X, 24519162
Coverage and History 2019-2021
Best Quartile Q4
Total Citations Received
(Last 3 Year)
5

About Frontiers in Anti-infective Drug Discovery


Frontiers in Anti-infective Drug Discovery is a book series published by Bentham Science Publishers B.V.. This book series covers the area[s] related to Drug Discovery, Infectious Diseases, Molecular Medicine, etc. The coverage history of this book series is as follows: 2019-2021. The rank of this book series is 23295. This book series's impact score, h-index, and SJR are 1.00, 2, and 0.131, respectively. The ISSN of this book series is/are as follows: 1879663X, 24519162.

The best quartile of Frontiers in Anti-infective Drug Discovery is Q4. This book series has received a total of 5 citations during the last three years (Preceding 2022).


Frontiers in Anti-infective Drug Discovery Impact Score 2022-2023


The latest impact score (IS) of the Frontiers in Anti-infective Drug Discovery is 1.00. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Graph


Check below the Impact Score trends of Frontiers in Anti-infective Drug Discovery. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.00
2021 0.33
2020 0.00
2019 0.00

Frontiers in Anti-infective Drug Discovery h-index


  Table Setting

The h-index of Frontiers in Anti-infective Drug Discovery is 2. By definition of the h-index, this book series has at least 2 published articles with more than 2 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Frontiers in Anti-infective Drug Discovery ISSN


The International Standard Serial Number (ISSN) of Frontiers in Anti-infective Drug Discovery is/are as follows: 1879663X, 24519162.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Frontiers in Anti-infective Drug Discovery Ranking and SCImago Journal Rank (SJR)


The Frontiers in Anti-infective Drug Discovery is ranked 23295 among 27955 Journals, Conferences, and Book Series. As per SJR, this book series is ranked 0.131.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Frontiers in Anti-infective Drug Discovery Publisher


Table Setting

The publisher of Frontiers in Anti-infective Drug Discovery is Bentham Science Publishers B.V.. The publishing house of this book series is located in the Netherlands. Its coverage history is as follows: 2019-2021.


Call For Papers (CFPs)


Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Frontiers in Anti-infective Drug Discovery is Front. Anti-infect. Drug Discov.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Front. Anti-infect. Drug Discov.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Frontiers in Anti-infective Drug Discovery


If your area of research or discipline is related to Drug Discovery, Infectious Diseases, Molecular Medicine, etc., please check the book series's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Frontiers in Anti-infective Drug Discovery?

The latest impact score of Frontiers in Anti-infective Drug Discovery is 1.00. It is computed in the year 2023.


What is the h-index of Frontiers in Anti-infective Drug Discovery?

The latest h-index of Frontiers in Anti-infective Drug Discovery is 2. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Frontiers in Anti-infective Drug Discovery?

The latest SCImago Journal Rank (SJR) of Frontiers in Anti-infective Drug Discovery is 0.131. It is calculated in the year 2023.


What is the ranking of Frontiers in Anti-infective Drug Discovery?

The latest ranking of Frontiers in Anti-infective Drug Discovery is 23295. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Frontiers in Anti-infective Drug Discovery?

Frontiers in Anti-infective Drug Discovery is published by Bentham Science Publishers B.V.. The publication country of this book series is Netherlands.


What is the abbreviation of Frontiers in Anti-infective Drug Discovery?

This standard abbreviation of Frontiers in Anti-infective Drug Discovery is Front. Anti-infect. Drug Discov..


Is "Frontiers in Anti-infective Drug Discovery" a Journal, Conference or Book Series?

Frontiers in Anti-infective Drug Discovery is a book series published by Bentham Science Publishers B.V..


What is the scope of Frontiers in Anti-infective Drug Discovery?

The scope of Frontiers in Anti-infective Drug Discovery is as follows:

  • Drug Discovery
  • Infectious Diseases
  • Molecular Medicine

For detailed scope of Frontiers in Anti-infective Drug Discovery, check the official website of this book series.


What is the ISSN of Frontiers in Anti-infective Drug Discovery?

The International Standard Serial Number (ISSN) of Frontiers in Anti-infective Drug Discovery is/are as follows: 1879663X, 24519162.


What is the best quartile for Frontiers in Anti-infective Drug Discovery?

The best quartile for Frontiers in Anti-infective Drug Discovery is Q4.


What is the coverage history of Frontiers in Anti-infective Drug Discovery?

The coverage history of Frontiers in Anti-infective Drug Discovery is as follows 2019-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Indian Journal of Plastic Surgery Journal Thieme Medical Publishers Inc. 16018 37 0.65
Zeitschrift fur Germanistische Linguistik Journal De Gruyter Mouton 22945 15 0.19
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings 7015 49 2.14
Qualitative Research Journal SAGE Publications Ltd 2108 86 3.97
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Milan Journal of Mathematics Journal Birkhauser Verlag Basel 3120 28 1.79
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
Journal of Applied Business Research Journal 23890 29 0.28
Air and Space Power Journal (discontinued) Journal AU Press 28397 9 0.20

Check complete list




Frontiers in Anti-infective Drug Discovery Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.00
2021 0.33
2020 0.00
2019 0.00



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Infectious Diseases

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Lancet Microbe, The
Elsevier Ltd. | United Kingdom

Lancet Infectious Diseases, The
Lancet Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Drug Resistance Updates
Churchill Livingstone | United States

Clinical Infectious Diseases
Oxford University Press | United Kingdom

Lancet HIV,The
Elsevier Ltd. | United Kingdom

Journal of Infection
W.B. Saunders Ltd | United Kingdom

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

Clinical Microbiology and Infection
Elsevier Ltd. | United Kingdom

Cellular and Molecular Immunology
Nature Publishing Group | United Kingdom

Trends in Microbiology
Elsevier Ltd. | United Kingdom

FEMS Microbiology Reviews
Oxford University Press | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All